COMMERZBANK AKTIENGESELLSCHAFT /FI

Bank

Position in GILD — Gilead Sciences, Inc.

CIK 852933 FRANKFURT, 2M

Position in GILD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$5,252,080

-$2,379,263 QoQ

Shares Held

41,571

-24.1% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#570

of 2,266 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

COMMERZBANK AKTIENGESELLSCHAFT /FI holds $332,070,617 across 8 Drug Manufacturers - General names. GILD ranks #7 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	630,281	$160,072,465
2	AMGN	Amgen Inc	209,478	$75,856,173
3	LLY	ELI LILLY & Co	34,683	$41,599,834
4	MRK	Merck & Co., Inc.	215,121	$27,643,048
5	PFE	Pfizer Inc	444,778	$10,710,254
6	ABBV	AbbVie Inc.	39,227	$9,871,082
7	GILD	Gilead Sciences, Inc. This page	41,571	$5,252,080
8	BMY	Bristol Myers Squibb Co	18,495	$1,065,681

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,252,080	41,571	-24.1%	Shares	Sole	2026-08-07
2026-03-31	$7,631,343	54,756	-17.0%	Shares	Sole	2026-05-07
2025-12-31	$8,098,139	65,978	+429.1%	Shares	Sole	2026-02-05
2025-09-30	$1,384,281	12,471	-6.4%	Shares	Sole	2025-10-31
2025-03-31	$1,493,178	13,326	+27.4%	Shares	Sole	2025-05-02
2024-12-31	$966,467	10,463	+4.6%	Shares	Sole	2025-02-06
2024-09-30	$838,316	9,999	-50.8%	Shares	Sole	2024-10-22
2024-06-30	$1,395,252	20,336	+165.6%	Shares	Sole	2024-07-22
2024-03-31	$560,802	7,656	+64.4%	Shares	Sole	2024-05-10
2023-12-31	$377,182	4,656	-43.7%	Shares	Sole	2024-09-30
2022-09-30	$509,867	8,265	-87.0%	Shares	Sole	2024-10-02
2020-06-30	$4,892,306	63,586	-68.0%	Shares	Sole	2024-10-03
2020-03-31	$14,835,449	198,441	—	Shares	Sole	2024-10-03
No filing history on record for this holder in this stock.